Healthcare provider profile · identity verified

Valentina Polyak, M.D.

Internal Medicine · GURNEE, IL · NPI 1114913845

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	224	66
Lisinopril	Lisinopril	222	53
Amlodipine Besylate	Amlodipine Besylate	200	59
Levothyroxine Sodium	Levothyroxine Sodium	198	51
Atorvastatin Calcium	Atorvastatin Calcium	189	55
Losartan Potassium	Losartan Potassium	180	50
Metformin Hcl	Metformin Hcl	140	36
Metoprolol Succinate	Metoprolol Succinate	137	44
Rosuvastatin Calcium	Rosuvastatin Calcium	136	44
Gabapentin	Gabapentin	103	30
Glimepiride	Glimepiride	99	33
Alendronate Sodium	Alendronate Sodium	88	26
Metoprolol Tartrate	Metoprolol Tartrate	88	20
Omeprazole	Omeprazole	88	27
Furosemide	Furosemide	84	29
Albuterol Sulfate Hfa	Albuterol Sulfate	82	22
Carvedilol	Carvedilol	80	18
Hydrochlorothiazide	Hydrochlorothiazide	73	22
Pantoprazole Sodium	Pantoprazole Sodium	73	21
Pravastatin Sodium	Pravastatin Sodium	68	16
Metformin Hcl Er	Metformin Hcl	63	20
Eliquis	Apixaban	62	13
Allopurinol	Allopurinol	51	16
Hydralazine Hcl	Hydralazine Hcl	49	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	14
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Spironolactone	Spironolactone	48	18
Methylprednisolone	Methylprednisolone	46	36
Potassium Chloride	Potassium Chloride	44	13
Tramadol Hcl	Tramadol Hcl	41	11
Jardiance	Empagliflozin	40	suppressed
Lovastatin	Lovastatin	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Alprazolam	Alprazolam	34	11
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	34	13
Valsartan	Valsartan	33	suppressed
Atenolol	Atenolol	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Famotidine	Famotidine	28	suppressed
Amoxicillin	Amoxicillin	27	16
Clonazepam	Clonazepam	27	suppressed
Lorazepam	Lorazepam	26	suppressed
Nitroglycerin	Nitroglycerin	26	11
Azithromycin	Azithromycin	25	21
Celecoxib	Celecoxib	23	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Pentoxifylline	Pentoxifylline	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Ozempic	Semaglutide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Sertraline Hcl	Sertraline Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Torsemide	Torsemide	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Famciclovir	Famciclovir	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Latanoprost	Latanoprost	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error